Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Total Debt (2011 - 2015)

Updated

Atossa Therapeutics' Total Debt was $12,531 in Q2 2015, down 50.3% from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Total Debt (2011 - 2015) Analysis & Trends

At the end of FY2014, Total Debt at Atossa Therapeutics came in at $49,216, up 745.6% from FY2013.

  • Total Debt shows a three-year compound annual growth rate of -63.4% (FY2011 to FY2014).
  • In earlier years, Total Debt was $5,820 in FY2013 and $1.01 million in FY2011.
  • The Q2 2015 figure marks the lowest quarterly Total Debt since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 12,531.00
Mar 31, 2015 25,230.00
Dec 31, 2014 49,216.00
Dec 31, 2013 5,820.00
Sep 30, 2012 330,453.00
Dec 31, 2011 1.01 Mn
API Access

Atossa Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ATOS&period=max&api_key=YOUR_API_KEY